Echocardiography (Mount Kisco, N.Y.) · 2025
Role of Real-Time 3D-Echocardiography in Predicting Success of Redo-Percutaneous Balloon Mitral Valvuloplasty.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Walse Rohit, Pant Bhagwati, Sivadasapillai Harikrishnan, Ganapathi Sanjay, Valaparambil Ajitkumar
Аннотация
BACKGROUND: Echocardiographic predictors of procedural success of redo-percutaneous balloon mitral valvuloplasty (redo-pBMV) have not been extensively studied, and current indications are primarily based on the Wilkins score (WS).
AIM: This study aims to evaluate the role of real-time 3D echocardiography in predicting the success rates of redo-pBMV.
METHODOLOGY: We analyzed 42 patients who underwent pBMV at our center from January 2022 to November 2022. These patients were divided into two groups: Group I (patients undergoing redo-pBMV) and Group II (patients undergoing pBMV for the first time). Immediate procedural outcomes were assessed, and the 3D echocardiographic score was compared with the traditional WS.
RESULTS: The mean WS was 9.69 ± 1.08 in Group I, compared to 9.5 ± 1.33 in Group II (p = 0.575). The 3D echocardiographic analysis revealed a numerically higher 3D score in Group I (11.2 ± 1.83 vs. 10.9 ± 1.52, p = 0.631). ROC curve analysis showed an area under the curve (AUC) of 0.9785 for the 3D score, indicating that it was a better predictor of success compared to the WS (ROC AUC = 0.8289).
CONCLUSION: The real-time 3D echocardiographic score provides a detailed morphological assessment of the mitral valve and was found to be a better predictor of procedural success than the traditional WS in patients undergoing redo mitral stenosis intervention.
AIM: This study aims to evaluate the role of real-time 3D echocardiography in predicting the success rates of redo-pBMV.
METHODOLOGY: We analyzed 42 patients who underwent pBMV at our center from January 2022 to November 2022. These patients were divided into two groups: Group I (patients undergoing redo-pBMV) and Group II (patients undergoing pBMV for the first time). Immediate procedural outcomes were assessed, and the 3D echocardiographic score was compared with the traditional WS.
RESULTS: The mean WS was 9.69 ± 1.08 in Group I, compared to 9.5 ± 1.33 in Group II (p = 0.575). The 3D echocardiographic analysis revealed a numerically higher 3D score in Group I (11.2 ± 1.83 vs. 10.9 ± 1.52, p = 0.631). ROC curve analysis showed an area under the curve (AUC) of 0.9785 for the 3D score, indicating that it was a better predictor of success compared to the WS (ROC AUC = 0.8289).
CONCLUSION: The real-time 3D echocardiographic score provides a detailed morphological assessment of the mitral valve and was found to be a better predictor of procedural success than the traditional WS in patients undergoing redo mitral stenosis intervention.